Zhou X G, Wang Y C, Yu B M, Shen Y X, Chen Z R, Lin L H, Yang J S, Zhang D S, Ding Q G, Ma L
Ruijin Hospital, Shanghai Second Medical College.
Zhonghua Zhong Liu Za Zhi. 1988 May;10(3):220-3.
From March 1981 to October 1985, 5-Fu was preoperatively given to 65 Dukes B and C rectal cancer patients (intrarectal suppository 40 and emulsion 20, intravenous 5). The results indicated that after intrarectal administration, marked changes and destruction of the cancer cells in morphology were observed in 40% of the resected rectal specimens for suppository and in 45% for emulsion; marked retrograde degeneration in ultrastructure was found in 47.5% for suppository and in 50% for emulsion; DNA synthesis was obviously reduced in 63% for suppository and in 75% for emulsion. It is suggested that the emulsion be a better preparation. No obvious changes or destruction in morphology and ultrastructure were observed in cancer cells treated by intravenous drip of high dose 5-Fu though leukopenia below 4000 was found in 2/5. However, it was 0/60 by rectal administration. This implies that the intrarectal route is more rational than the conventional intravenous route. This study presents an alternate supplementary treatment in addition to radiotherapy for the reduction of postoperative local recurrence of Dukes B and C rectal cancers.
1981年3月至1985年10月,对65例 Dukes B期和C期直肠癌患者术前给予5-氟尿嘧啶(5-Fu)(直肠栓剂40例,乳剂20例,静脉给药5例)。结果显示,直肠给药后,栓剂组40%的切除直肠标本及乳剂组45%的切除直肠标本中观察到癌细胞形态有明显改变和破坏;栓剂组47.5%及乳剂组50%的标本超微结构出现明显逆行性退变;栓剂组63%及乳剂组75%的标本DNA合成明显减少。提示乳剂是一种更好的制剂。高剂量5-Fu静脉滴注治疗的癌细胞在形态和超微结构上未观察到明显改变或破坏,尽管5例中有2例白细胞计数低于4000,但直肠给药组60例中白细胞计数低于4000的为0例。这意味着直肠给药途径比传统静脉给药途径更合理。本研究为降低 Dukes B期和C期直肠癌术后局部复发提供了一种除放疗外的替代辅助治疗方法。